Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Phase I Clinical Trial of a Selective Inhibitor of CYP17, Abiraterone Acetate, Confirms That Castration-Resistant Prostate Cancer Commonly Remains Hormone Driven
PaperCitations, authors & open-access status
Phase I Clinical Trial of a Selective Inhibitor of CYP17, Abiraterone Acetate, Confirms That Castration-Resistant Prostate Cancer Commonly Remains Hormone Driven is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 903 citations, 2008 year and bronze oa status.
903
Citations
2008
Year
bronze
OA Status